Related Experiment Videos

[Alveolar proteinosis and occupational exposure]

P Chariot¹, I Monnet, H De Cremoux

¹Clinique de Pathologie Respiratoire et Environnement, Centre Hospitalier Intercommunal de Créteil.

Annales De Medecine Interne

|January 1, 1991

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.

ESMO open·2021

Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST study.

Respiratory medicine and research·2020

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

See all related articles